PROFIL KLINIS DAN GABUNGAN TERAPI PASIEN TERDIAGNOSIS OTOMIKOSIS DI POLIKLINIK THT-KL RSUD WALED PERIODE TAHUN 2018-2022

Febiana Zulhaidah; Pahmi Budiman; Edy Riyanto Bakri; Febryanti Purnamasari; Nanang Ruhyana; Niklah Zaidah

Authors

Febiana Zulhaidah Fakultas Kedokteran UGJ Cirebon, Indonesia
Pahmi Budiman Fakultas Kedokteran UGJ Cirebon, Indonesia
Edy Riyanto Bakri Fakultas Kedokteran UGJ Cirebon, Indonesia
Febryanti Purnamasari Fakultas Kedokteran UGJ Cirebon, Indonesia
Nanang Ruhyana Fakultas Kedokteran UGJ Cirebon, Indonesia
Niklah Zaidah Fakultas Kedokteran UGJ Cirebon, Indonesia

Keywords:

Otomycosis, Infeksi, Gabungan terapi.

Abstract

Latar belakang: Otomikosis merupakan infeksi jamur, disebabkan oleh jamur Aspergillus Sp dan Candida Spp yang menyerang bagian meatus akustikus eksternus. Prevalensi otomikosis di seluruh dunia antara 30-40% kasus yang biasanya terjadi di daerah tropis dan subtropis. Keluhan yang muncul adalah pruritus dan diikuti dengan otalgia. Faktor predisposisi otomikosis yaitu penggunaan obat tetes telinga, sering berenang, penggunaan cotton bud pada telinga dan pengguna alat bantu dengar. Tatalaksana pada pasien otomikosis diberikan terapi irigasi telinga, kompres telinga, obat topikal tetes ataupun salep, dan oral. Tujuan: Mengetahui profil klinis dan gabungan terapi pasien terdiagnosis Otomikosis di poliklinik THT-KL RSUD Waled. Metode: Penelitian deskriptif retrospektif menggunakan total sampling data rekam medis pasien yang terdiagnosis Otomikosis di poliklinik THT-KL RSUD Waled periode 2018-2022. Pasien yang didiagnosis otomikosis tanpa gangguan telinga lain masuk dalam kriteria inklusi. Pasien yang datanya tidak lengkap masuk dalam kriteria ekslusi. Hasil: Terdapat 56 pasien terdiagnosis otomikosis dengan laki-laki 20 pasien (35,7%) dan perempuan 36 pasien (64,3%). Mayoritas IRT 39,3%, dengan rentang usia terbanyak 26-45 tahun (46,4%). Kebanyakan pasien mengeluhkan gatal 76,8% pasien. Diikuti oleh keluhan lainnya yaitu otalgia 62,5%, rasa penuh di telinga 44,6%, tinnitus 39,3%, ottorhea 35,7%, dan gangguan pendengaran 17,9%. Mayoritas pasien mendapat gabungan terapi topikal dan oral sebanyak 35,7% pasien. Kesimpulan: Otomikosis banyak menginfeksi perempuan khususnya IRT dengan rentang umur 26-45 tahun. Gejala yang banyak muncul yaitu pruritus dan otalgia.

Kata Kunci: Otomikosis, Infeksi, Gabungan terapi.

ABSTRACT

Background: Otomycosis is a fungal infection, caused by Aspergillus Sp and Candida Spp which attack the canal external auditory. The prevalence of otomycosis worldwide is between 30-40% of cases, which usually occurs in tropical and subtropical regions. The most common symptomps are pruritus and usually followed by otalgia. Main predisposing factors of otomycosis are the use of ear drops, swimming, use of cotton buds in the ear, and hearing aid users. Management of otomycosis patients is usually given ear toilet, ear tampons, topical drops or ointments, and oral medication. Objective: The aims in this study to determine the clinical profile and combined therapy of Otomycosis patients at the ENT clinic at Waled Hospital for the period 2018-2022. Methods: A retrospective descriptive study using total sampling medical record data of patients diagnosed with otomycosis at the ENT-KL polyclinic at Waled Hospital period 2018-2022. Patients diagnosed with otomycosis without other ear disorders were included. Patients with incomplete data were exluded. Results: This study found 56 patients diagnosed with otomycosis with 20 male patients (35.7%) and 36 female patients (64.3%). The majority were housewives (39,3%) with an age range of 26-45 years (46,4%). Most patients complain of pruritus 76.8%. Followed by other symptoms, otalgia 62.5%, ear fullness 44.6%, tinnitus 39.3%, otorrhea 35.7% and hearing loss 17.9%. Most patients received a combination of topical and oral therapy with 35.7% of patients. Conclusion: Otomycosis was common in female population especially in housewives, in the age range 26-45 years. Predominant symptoms were pruritus and otalgia.

References

Daftar Pustaka

Agoeng HP. Efektifitas Terapi Otomycosis Menggunakan Miconazole dan Ear Toilet terhadap Tingkat Kekambuhan: Laporan Serial Kasus. Jurnal Kedokteran Nanggroe Medika. 2020 des;3(10):45-52.

Kiakojori K, Jamnani NB, Khafri S, and Omran SM. Assessment of Response to Treatment in Patients with Otomycosis. Iran J Otorhinolaryngol. 2018 jan;30(1):41-7.

Marlinda L dan Aprilia E. Otomikosis Auris Dekstra pada Perenang. J Medula Unila. 2016 des;6(1):67–71.

Sangare I, Amona FM, Ouedraogo RW, Zida A, and Ouedraogo MS. Otomycosis in Africa: Epidemiology, diagnosis and treatment. Journal of Medical Mycology. 2021 jan.

Jeena T, Jayaprabha S, Satheesh S, and Sahira H. Clinical and Microbiological Profile of Otomycosis Among Patients Attending a Tertiary Care Center. International Journal of Health and Clinical Research. 2021 jan;4(3):86-9.

Nipa KK, Kamal AHM, and Imtiaj A. Prevalence and Clinicomycological Studies Of Otomycosis: A Review. J. Bio-Sci. 2020;28:121-135.

Sarwestani HK, Ghazvini RD, Hashemi SJ, Reaie S, Shoar MG, Mahmoudi S, Elahi M, and Tajdini A. Investigation of Etiologic Agents and Clinical Presentations of Otomycosis at a Tertiary Referral Center in Tehran, Iran. Iran J Public Health. 2019 feb;48(2):331-7.

Agarwal P and Devi LS. Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents. Journal of Clinical and Diagnostic Research. 2017 Jun;11(6):14-8.

Gharaghani M, Seifi Z, and Mahmoudabadi AZ. Otomycosis in Iran: A Review. Mycopathologia. 2015 jan.

Ismail MT, Al-Kafri A, and Ismail M. Otomycosis in Damascus, Syria: Etiology and clinical features. Current Medical Mycology. 2017 des;3(3):27–30.

Yahia S, Abdulmageed A and Mokhtar GA. Fungal Profile of Otomycosis in a Sample of Egyptian Patients in Zagazig University Hospitals: A prospective study. Microbes and Infectious Diseases. 2021 nov; 2(1): 143-51.

Zed AA and Phan T. Tympanic Membrane Perforation Secondary to Aspergillus Niger Otomycosis. Elsevier. 2020 aug.

Soepardi EA. Iskandar N, Bashiruddin J, dan Restuti RD. Buku Ajar Ilmu Kesehatan Telinga Hidung Tenggorok Kepala dan Leher. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2017.

Garciaa LJ, Aguilar EC, Pavona GD, Estrada VM, Urquizo AC, Castillo NH and Flores EA. Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial. Braz J Otorhinolaryngol. 2020;86(3):300-7.

Edward Y dan Irfandy D. Laporan Kasus Otomycosis. Jurnal Kesehatan Andalas. 2012;1(2):101-6.

Sanna M, Russo A and Donato GD. Color Atlas of Otoscopy From Diagnosis to Surgery. Italy: Thieme; 1999.

Sulaiman E, Purwanto B, Lasminingrum L, Dewi YA dan Mahdiani S. Potency of Vinegar Therapy in Otomycosis Patients. Journal of Medicine and Health. 2015;1(2):143-55.

Aremu SK, Adewoye KR, and Ibrahim T. A Prospective Analysis of Otomycosis in a Tertiary Care Hospital. Clinmed International Library. 2020;3(1):1-8.

Itabangi H, Katawera V, Nyaitera V, et al. Otomycosis among Patients Presenting with Ear Discharges at a Tertiary Hospital in South Western Uganda. International Journal of Tropical Disease & Health. 2018;32(2):1-9.

Haq M and Deshmukh P. Review of Recurrent Otomycosis and Clotrimazole in Its Treatment. 2022;14(10):1-6.

Li Y and He L. Diagnosis and treatment of otomycosis in southern China. 2019.

Kryukov AI, Kunel'skaya NL 1, Kunel'skaya VY, Ivoilov AY, Turovskiy AB, Shadrin GB, Machulin AI. Otomycosis: the modern view of etiology and management. 2018;83(1):48-51.

Bojanovic M, Stalevic M, Arsenijevic VA, et al. Etiology, Predisposing Factors, Clinical Features and Diagnostic Procedure of Otomycosis: A Literature Review. 2023.